Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | ReutersNovo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a…